Neerinckx B[au] - Search Results

Year	Number of Results
2013	1
2014	3
2015	2
2017	3
2021	5
2022	1

1

Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome.

Staels F, Betrains A, Woei-A-Jin FJSH, Boeckx N, Beckers M, Bervoets A, Willemsen M, Neerinckx B, Humblet-Baron S, Blockmans DE, Vanderschueren S, Schrijvers R. Staels F, et al. Among authors: neerinckx b. Front Immunol. 2021 Apr 23;12:678927. doi: 10.3389/fimmu.2021.678927. eCollection 2021. Front Immunol. 2021. PMID: 34046042 Free PMC article.

2

Palmar fasciitis and polyarthritis: an uncommon but remarkable paraneoplastic syndrome.

Celen H, Neerinckx B. Celen H, et al. Among authors: neerinckx b. Clin Rheumatol. 2021 Jun;40(6):2507-2508. doi: 10.1007/s10067-020-05552-z. Epub 2021 Jan 27. Clin Rheumatol. 2021. PMID: 33502626 No abstract available.

3

Mechanisms, impact and prevention of pathological bone regeneration in spondyloarthritis.

Neerinckx B, Lories R. Neerinckx B, et al. Curr Opin Rheumatol. 2017 Jul;29(4):287-292. doi: 10.1097/BOR.0000000000000404. Curr Opin Rheumatol. 2017. PMID: 28376064 Review.

4

Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

Neerinckx B, Lories RJ. Neerinckx B, et al. Curr Rheumatol Rep. 2017 Mar;19(3):14. doi: 10.1007/s11926-017-0639-7. Curr Rheumatol Rep. 2017. PMID: 28265849 Review.

5

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8.

Metzemaekers M, Abouelasrar Salama S, Vandooren J, Mortier A, Janssens R, Vandendriessche S, Ganseman E, Martens E, Gouwy M, Neerinckx B, Verschueren P, De Somer L, Wouters C, Struyf S, Opdenakker G, Van Damme J, Proost P. Metzemaekers M, et al. Among authors: neerinckx b. Front Immunol. 2021 Mar 11;12:644725. doi: 10.3389/fimmu.2021.644725. eCollection 2021. Front Immunol. 2021. PMID: 33777041 Free PMC article.

6

Correction to: Palmar fasciitis and polyarthritis: an uncommon but remarkable paraneoplastic syndrome.

Celen H, Neerinckx B. Celen H, et al. Among authors: neerinckx b. Clin Rheumatol. 2021 Mar;40(3):1209. doi: 10.1007/s10067-021-05632-8. Clin Rheumatol. 2021. PMID: 33555461 No abstract available.

7

Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis.

Orbai AM, Weitz J, Siegel EL, Siebert S, Savage LJ, Aydin SZ, Luime JJ, Elkayam O, Neerinckx B, Urbancek S, de Vlam K, Ritchlin CT; GRAPPA Enthesitis Working Group. Orbai AM, et al. Among authors: neerinckx b. J Rheumatol. 2014 Nov;41(11):2290-4. doi: 10.3899/jrheum.140878. J Rheumatol. 2014. PMID: 25362713 Review.

8

Evolution of patient characteristics in the era of biologic treatment of psoriatic arthritis: 18-year Belgian experience from the Leuven Spondyloarthritis Biologics Cohort (BioSPAR).

Ishchenko A, Joly J, Neerinckx B, Lories R, de Vlam K. Ishchenko A, et al. Among authors: neerinckx b. Rheumatol Adv Pract. 2021 Nov 15;5(3):rkab085. doi: 10.1093/rap/rkab085. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 34888434 Free PMC article.

9

Spreading spondyloarthritis: are ILCs cytokine shuttles from base camp gut?

Neerinckx B, Elewaut D, Lories RJ. Neerinckx B, et al. Ann Rheum Dis. 2015 Sep;74(9):1633-5. doi: 10.1136/annrheumdis-2015-207735. Epub 2015 Jul 21. Ann Rheum Dis. 2015. PMID: 26199396 No abstract available.

10

No evidence for a direct role of HLA-B27 in pathological bone formation in axial SpA.

Neerinckx B, Kollnberger S, Shaw J, Lories R. Neerinckx B, et al. RMD Open. 2017 Jun 29;3(1):e000451. doi: 10.1136/rmdopen-2017-000451. eCollection 2017. RMD Open. 2017. PMID: 28879048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results